These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11388054)

  • 1. [Development of the incidence and mortality of breast cancer].
    Becker N
    Radiologe; 2001 Apr; 41(4):337-43. PubMed ID: 11388054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of colorectal cancer].
    Becker N
    Radiologe; 2003 Feb; 43(2):98-104. PubMed ID: 12624666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening mammography and its significance for decreasing breast cancer mortality].
    Frischbier HJ
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):995-9. PubMed ID: 1776292
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of effectiveness of quality-assured mammography screening in Germany: sample size considerations and design options.
    Becker N; Hakama M; Nyström L
    Eur J Cancer Prev; 2007 Jun; 16(3):225-31. PubMed ID: 17415093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969-1997.
    Broeders MJ; Peer PG; Straatman H; Beex LV; Hendriks JH; Holland R; Verbeek AL
    Int J Cancer; 2001 Apr; 92(2):303-8. PubMed ID: 11291061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the early impact of the population-based breast cancer screening programme in Florence (Italy) using mortality and surrogate measures.
    Paci E; Giorgi D; Bianchi S; Vezzosi V; Zappa M; Crocetti E; Rosselli del Turco M
    Eur J Cancer; 2002 Mar; 38(4):568-73. PubMed ID: 11872351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.
    Swedish Organised Service Screening Evaluation Group
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):45-51. PubMed ID: 16434585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological aspects of cancer screening in Germany.
    Becker N
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):691-702. PubMed ID: 14557878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.
    Otten JD; Broeders MJ; Fracheboud J; Otto SJ; de Koning HJ; Verbeek AL
    Int J Cancer; 2008 Oct; 123(8):1929-34. PubMed ID: 18688863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
    Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
    BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of service screening on breast cancer mortality rates.
    Cox B
    Eur J Cancer Prev; 2008 Aug; 17(4):306-11. PubMed ID: 18562953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why is breast-cancer mortality declining?
    Jatoi I; Miller AB
    Lancet Oncol; 2003 Apr; 4(4):251-4. PubMed ID: 12681269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative estimates of the impact of sensitivity and specificity in mammographic screening in Germany.
    Warmerdam PG; de Koning HJ; Boer R; Beemsterboer PM; Dierks ML; Swart E; Robra BP
    J Epidemiol Community Health; 1997 Apr; 51(2):180-6. PubMed ID: 9196649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast cancer mortality in women in the Schleswig-Holstein district 1981 to 1995].
    Heitmann C; Bauer A; Hoffmann W; Kruse H
    Gesundheitswesen; 2001 Jun; 63(6):383-91. PubMed ID: 11467221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in breast cancer mortality, incidence, and survival, and mammographic screening in Tuscany, Italy.
    Barchielli A; Paci E
    Cancer Causes Control; 2001 Apr; 12(3):249-55. PubMed ID: 11405330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.